ARK Genomic Revolution ETF vs LTC Properties Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while LTC Properties Inc trades at $39.39 (market cap $1.99B). The key difference: LTC Properties Inc pays a 5.87% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | LTC | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $40.36 |
52-Week Low | $23.09 | $33.98 |
Market Cap | — | $1.99B |
Enterprise Value | — | $2.84B |
Dividend Yield | — | 5.87% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
LTC Properties trades at $38.86, down 0.72% on the day, with a bullish technical signal from moving averages and a neutral RSI. The REIT shows strong profitability with a 39.09% net income margin and a P/E of 15.24. Recent acquisitions, including a $73 million SHOP portfolio expansion (Business Wire, 2026-07-08), highlight growth initiatives, while consistent monthly dividends of $0.19 provide income appeal.
The outlook is mixed: analyst consensus leans Hold (59.09%) amid recent earnings misses, but bullish technicals and strategic shifts to seniors housing offer upside. Risks include execution on SHOP transitions and debt levels, with net cash flow turning negative in 2026. Investors should weigh growth potential against margin pressures and macroeconomic sensitivity.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →